Viewing StudyNCT00000803



Ignite Creation Date: 2024-05-05 @ 11:20 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000803
Status: COMPLETED
Last Update Posted: 2021-11-04
First Post: 1999-11-02

Brief Title: A Phase II Double-Blind Study of Delavirdine Mesylate U-90152 in Combination With Zidovudine AZT andor Didanosine ddI Versus AZT and ddI Combination Therapy
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
Zidovudine View
Didanosine View
Drug Therapy Combination View
Acquired Immunodeficiency Syndrome View
AIDS-Related Complex View
Antiviral Agents View